Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

BACKGROUND: Previous studies have suggested an association between the use of direct‐acting antiviral agents (DAAs) for treating hepatitis C virus (HCV) infection and the resulting decrease in the incidence of hepatocellular carcinoma (HCC); however, it is unclear whether DAAs prevent the recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Masahito, Koga, Hironori, Ide, Tatsuya, Kuromatsu, Ryoko, Hashimoto, Satoru, Yatsuhashi, Hiroshi, Seike, Masataka, Higuchi, Nobito, Nakamuta, Makoto, Shakado, Satoshi, Sakisaka, Shotaro, Miuma, Satoshi, Nakao, Kazuhiko, Yoshimaru, Yoko, Sasaki, Yutaka, Oeda, Satoshi, Eguchi, Yuichiro, Honma, Yuichi, Harada, Masaru, Nagata, Kenji, Mawatari, Seiichi, Ido, Akio, Maeshiro, Tatsuji, Matsumoto, Shuichi, Takami, Yuko, Sohda, Tetsuo, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536965/
https://www.ncbi.nlm.nih.gov/pubmed/30900818
http://dx.doi.org/10.1002/cam4.2061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536965/
https://www.ncbi.nlm.nih.gov/pubmed/30900818
http://dx.doi.org/10.1002/cam4.2061

Ejemplares similares